Gedeon Christelle sold $57K of CGC

Gedeon Christelle (See Remarks) sold 58,994 shares of Canopy Growth Corp (CGC) at $0.97 on 2026-06-17.

Original reporting
SEC EDGAR · Gedeon Christelle
Published Jun 22, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 22, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CGC
Neutral
medium confidence
Mentioned
$CGC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CGCNeutralLow
01

Why it matters

The newest disclosed fact is the open-market sale of 58,994 shares at $0.9741/share for ~$57.5K, with holdings after sale of 705,506 shares.

02

Market read

Provides incremental transparency on insider behavior, but lacks accompanying fundamental catalysts.

03

What to watch

Insider sales are often non-informational; traders should check whether there were concurrent buys/sales by other insiders and whether the company had any contemporaneous news or guidance changes.

Relevance 3/10Novelty 5/10Timing: Filed 2026-06-22 after-hours; reflects sale executed 2026-06-17.

Background

SEC Form 4 insider transaction for Canopy Growth Corp (CGC) reported by officer Gedeon Christelle.

Company-level read

Ticker impact

$CGCNeutralMedium confidence
Context

Form 4 shows officer Gedeon Christelle sold 58,994 CGC shares in an open-market transaction on 2026-06-17.

Expected impact

Near-term price impact likely minimal; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and a small-to-moderate dollar value, but insider sales alone rarely drive sustained repricing without accompanying company-specific news.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could be interpreted as discretionary selling, but it may also reflect diversification/tax liquidity rather than bearish fundamentals.

Key entities

  • Canopy Growth Corp

    Subject of the Form 4 insider sale disclosure.

  • Gedeon Christelle

    Officer who sold 58,994 shares of CGC on 2026-06-17.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CGCMed

Canopy Growth (CGC) Q2 2027 Earnings Call Transcript

Canopy Growth (CGC) reported Q2 2027 revenue of $81.4M, up 22% YoY, driven by 30% cannabis segment growth. Medical cannabis and international markets showed momentum, while Storz & Bickel revenue fell 44% YoY to $50.1M. The company expects improved yields and EU GMP certifications to boost growth and margins. Adjusted EBITDA loss narrowed to $2.9M, with a target of profitability in H2 2027.

$CGCMedAI 8/10

Canopy Growth Corporation Q2 2027 Earnings Call Summary

Canopy Growth reported Q2 2027 results, highlighting a 141% YoY increase in international cannabis revenue and a 44% decline in Storz & Bickel revenue due to economic uncertainty. The company aims for positive adjusted EBITDA in H2 2027, with cultivation improvements expected to boost flower production by 25-30% in early 2028. Canopy also secured EU GMP certification, enabling expansion into European markets beyond dry flower.

$CGCMed

Canopy Growth Q2 Earnings Call Highlights

Canopy Growth reported Q2 revenue growth in Canada and plans to build a dedicated sales force. Storz & Bickel revenue declined 4% but expects a strong Q3. Cultivation improvements aim for 25-30% yield increase. Adjusted gross margin fell to 31% from 33% due to VA reimbursement rate changes. Cash reserves were CAD 320 million as of September 30. The company may pursue a reverse stock split to maintain Nasdaq compliance.